Dergiler / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 1

Evaluation of the Demographic and Clinical Data of Psoriasis Patients: A Detailed Analysis of a Big Series

Sayfa
72–77
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The follow-up and treatment of patients with psoriasis are important in terms of comorbidities.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Psoriasis is a chronic disease and requires follow-up settings to manage.
📊
Temel Bulgular & Veri:Methods: Clinical data from patients who were followed in the University of Health Sciences Turkey, Haseki Training and Research Hospital psoriasis outpatient clinic between January 2015 and March 2021 were examined.
💡
Sonuç & Katkı:The follow-up and treatment of patients with psoriasis are important in terms of comorbidities.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Psoriasis is a chronic disease and requires follow-up settings to manage. The aim of the study is to evaluate the clinical characteristics, disease course, the factors associated with the psoriasis area severity score index (PASI), comorbidities, and treatment of psoriasis in our follow-up psoriasis outpatient clinic. Methods: Clinical data from patients who were followed in the University of Health Sciences Turkey, Haseki Training and Research Hospital psoriasis outpatient clinic between January 2015 and March 2021 were examined. The relationships between age, age of the disease onset, gender, joint involvement, and nail involvement were analyzed. Results: In total, 618 patients were included in our study (320 males and 298 females). The median age of the patients was 42 (1- 87) years. Family history was present in 25.9% of the patients. The most common clinical type was plaque psoriasis (80.2%). The median value of the PASI was 8.1. The disease course of the patients was progressive (46.4%), remission and exacerbations (37%), and regressive (16.7%). Nail involvement and joint involvement were observed in 58.1% and 24.2% of the patients, respectively. A significant correlation was found between PASI and joint involvement (p=0.009). Onycholysis (a type of nail involvement) was a positive predictive indicator for joint involvement (p=0.004). Comorbidity was present in 34.5% of the patients. Obesity, hypertension, diabetes mellitus, and dyslipidemia were the most common comorbidities. While 19.9% of the patients received only topical treatment, 80.1% underwent systemic treatment. Conclusions: The socio-demographic and enriched clinical data of psoriasis highlight the features that should be considered, especially in follow-up outpatient clinics. Patients showing an early onset of the disease should be investigated for severe involvement, such as the presence of onycholysis in the nail or evidence of joint involvement. The follow-up and treatment of patients with psoriasis are important in terms of comorbidities.

🔖

Bu Makaleye Atıf Yap

CAF, N., TUFAN, A. N., DEMİR, F. T., AKBULUT, T. Ö., AĞIRGÖL, S., TÜRKOĞLU, Z., CAYHAN, B. (2022). Evaluation of the Demographic and Clinical Data of Psoriasis Patients: A Detailed Analysis of a Big Series. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 1, 72–77. https://ajindex.com/articles/534935

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:1511
  2. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013;133:377-85
  3. Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol 2021;84:46-52
  4. Kundakci N, Türsen U, Babiker MO, Gürgey E. The evaluation of the socio-demographic and clinical features of Turkish psoriasis patients. Int J Dermatol 2002;41:220-4
  5. Tekin NS, Koca R, Altınyazar HC, Çınar S, Muhtar Ş, Aslaner NN. Zonguldak bölgesindeki psoriasis hastalarının sosyodemografik ve klinik özelliklerinin değerlendirilmesi. Turkiye Klinikleri J Dermatol 2005;15:141-6
  6. Aykol C, Mevlitoğlu İ, Özdemir M, Ünal M. Konya Yöresindeki Psoriasis Hastalarinin Klinik ve Sosyodemografik Özelliklerinin Degerlendirilmesi. Turk J Dermatol 2011;5:71-4
  7. Turan H, Acer E, Aliağaoğlu C, Uslu E, Albayrak H, Özşahin M. Psoriazisli Hastalarin Klinik ve Sosyodemografik Özelliklerinin Degerlendirilmesi. Turk J Dermatol 2013;7:76-80
  8. Rifaioglu EN, Özarmağan G. Clinical and demographic characteristics of 626 patients with moderate and severe psoriasis. J Clin Anal Med 2014;5:9-14
  9. Yaylı S, Topbaş M, Arıca DA, Tuğcugil S, Çapkın E, Bahadır S. The prevalence of psoriasis in Trabzon. Turkderm-Turk Arch Dermatol Venereol 2016;50:141-4
  10. Topal İO, Değirmentepe E, Cüre K, Kızıltaç U, Hökenek NB, Kocatürk E. Psoriasisli Hastaların Klinik ve Sosyodemografik Özelliklerinin Retrospektif Analizi. Eur Arc Med Res 2017;33:199-205
  11. Aksoy M, An İ. Psöriazis tanılı 298 hastanın klinik ve demografik özelliklerinin incelenmesi. Harran Üniversitesi Tıp Fakültesi Dergisi 2019;16:385-8
  12. Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002;46:867-73
  13. Kavanaugh A, Papp K, Gottlieb AB, et al. Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrol